Case Closed on < 1 Year of Trastuzumab for Breast Cancer Case Closed on < 1 Year of Trastuzumab for Breast Cancer

For early-stage breast cancer, the treatment duration of 1 year for trastuzumab was a guess. New research indicates it was a good guess.Medscape Medical News

Source: Medscape Medical News Headlines - August 25, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news